Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Petros Pharmaceuticals, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Petros Pharmaceuticals granted 7 million restricted shares to four key executives on June 5, 2026, with Joshua Silverman receiving the largest allocation of 4.375 million shares. This compensation action is designed to align leadership interests with shareholder value and incentivize long-term performance.
Key Takeaways
Total of 7 million restricted shares granted to executives: Joshua Silverman (4,375,000), Bruce Bernstein (1,875,000), Fady Boctor (375,000), and Wayne Walker (375,000)
Grant effective immediately on June 5, 2026, as part of compensatory arrangements for key leadership
2 more takeaways